Literature DB >> 15090559

X-linked adrenoleukodystrophy presenting as autosomal dominant pure hereditary spastic paraparesis.

C J Shaw-Smith1, S J G Lewis, E Reid.   

Abstract

We present a family in which an initial clinical diagnosis of autosomal dominant pure hereditary spastic paraparesis (HSP) was made on the basis of a three generation pedigree in which both males and females presented with a spastic paraparesis. Subsequent biochemical and genetic analysis revealed that the family was in fact affected by the adrenomyeloneuropathy subtype of X-linked adrenoleukodystrophy. In the family described, both males and females were affected by a spastic paraparesis, and there was no male to male transmission, consistent with both autosomal dominant and X-linked inheritance. This report illustrates the importance of assaying very long chain fatty acids (VLCFAs) in any HSP family where there is no male to male transmission.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15090559      PMCID: PMC1763580          DOI: 10.1136/jnnp.2003.022970

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  4 in total

Review 1.  Hereditary spastic paraplegia.

Authors:  John K Fink
Journal:  Curr Neurol Neurosci Rep       Date:  2006-01       Impact factor: 5.081

2.  Spastin tethers lipid droplets to peroxisomes and directs fatty acid trafficking through ESCRT-III.

Authors:  Chi-Lun Chang; Aubrey V Weigel; Maria S Ioannou; H Amalia Pasolli; C Shan Xu; David R Peale; Gleb Shtengel; Melanie Freeman; Harald F Hess; Craig Blackstone; Jennifer Lippincott-Schwartz
Journal:  J Cell Biol       Date:  2019-06-21       Impact factor: 10.539

Review 3.  Interorganelle communication, aging, and neurodegeneration.

Authors:  Maja Petkovic; Caitlin E O'Brien; Yuh Nung Jan
Journal:  Genes Dev       Date:  2021-04-01       Impact factor: 11.361

4.  Diagnosis, investigation and management of hereditary spastic paraplegias in the era of next-generation sequencing.

Authors:  Anke Hensiek; Stephen Kirker; Evan Reid
Journal:  J Neurol       Date:  2014-12-06       Impact factor: 4.849

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.